Experts argue there is no standard definition of metabolically healthy obesity, and most people convert over time to ...

Researchers now understand how soybean oil is linked to obesity. The study could affect HHS Sec. RFK Jr.'s new food regulations.

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

Dementia is a highly prevalent condition, affecting 57 million people worldwide, with nearly 10 million new cases each year, ...

President Trump has complained that wealthy countries like Britain pay too little for drugs, leading America to bear much of ...

Aim to go on a walk within an hour of eating your Thanksgiving meal, according to the University of Washington. Blood sugar ...

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

The March of Dimes report scored the U.S. overall a D+ grade on preterm birth rate at 10.4%, but states differ dramatically in their scores. New Hampshire, for example, scored an A- with 7.9% of ...

A large analysis of more than 11 million medical records found that people with untreated obstructive sleep apnea face a substantially higher risk of developing Parkinson’s disease over time.

The Broselow Tape is a color-coded length-based measure that is used across the globe for pediatric emergencies. The tape ...

Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...